Report overview
This report contains market size and forecasts of Atorvastatin API in global, including the following market information:
Global Atorvastatin API Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Atorvastatin API Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Atorvastatin API companies in 2022 (%)
The global Atorvastatin API market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
0.99 Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Atorvastatin API include Jiangsu Alpha Pharmaceutical, Jiangsu Yutian Pharmaceutical, Lunan Pharmaceutical, Nanjing Dorra Pharmaceutical Technology, Menovo Pharmaceutical, Shree HariKrishna Pharmaceutical, Tenatra Chemie, Centrient Pharmaceuticals and Dr. Reddy's Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Atorvastatin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atorvastatin API Market, by Purity, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Atorvastatin API Market Segment Percentages, by Purity, 2022 (%)
0.99
0.995
0.999
Others
Global Atorvastatin API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Atorvastatin API Market Segment Percentages, by Application, 2022 (%)
Medical Pharmaceutical
Scientific Research
Global Atorvastatin API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Atorvastatin API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atorvastatin API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Atorvastatin API revenues share in global market, 2022 (%)
Key companies Atorvastatin API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Atorvastatin API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jiangsu Alpha Pharmaceutical
Jiangsu Yutian Pharmaceutical
Lunan Pharmaceutical
Nanjing Dorra Pharmaceutical Technology
Menovo Pharmaceutical
Shree HariKrishna Pharmaceutical
Tenatra Chemie
Centrient Pharmaceuticals
Dr. Reddy's Laboratories
Teva API
Mangalam Drugs & Organics
Kyongbo Pharmaceutical
Apotex Pharmachem
Cadila Pharmaceuticals
Credo Life Sciences
